Pascal Soriot

change direction new plan alter arrows move reprioritize
Biotech

AstraZeneca relaxed about relaxin drug's poor efficacy in ph. 2

AstraZeneca executives have told Fierce Biotech they still see potential in harnessing the relaxin hormone to treat heart failure.
Pascal Soriot
Favicon Fierce Pharma

AZ reveals plan for huge site in Virginia, part of $50B US outlay

Jul 22, 2025 7:45am
pivot change turnaround direction walk away

AstraZeneca CEO defends 'fantastic' Alexion buy as halts drug

Feb 6, 2025 6:45am
AstraZeneca Cambridge Biomedical Campus aerial

AZ eyes China's explosion of innovation for cell therapy

May 21, 2024 8:27am
Pascal Soriot

AstraZeneca COVID-19 vaccine data hint at single-dose efficacy

Dec 9, 2020 7:40am
Pascal Soriot

AstraZeneca nears temporary OK for COVID-19 vaccine

Nov 30, 2020 4:46am